- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Paramivir is a synthetic cyclopentane derivative. Functional groups which get connected to the loop include hydrophilic carboxyl and guanidine groups, as well as hydrophobic isopentyl and acetamido groups. The four functional groups with different polarities act on different active site regions in the NA structure of influenza viruses. This medicine is suitable for the treatment of influenza A. It is mainly administered intravenously in the form of sodium chloride solution.
According to our latest study, the global Peramivir market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Peramivir market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Peramivir market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Kg), 2018-2029
Global Peramivir market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Kg), 2018-2029
Global Peramivir market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Kg), 2018-2029
Global Peramivir market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peramivir
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peramivir market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm and Moksha8 Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Peramivir market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Solution
Solid
Market segment by Application
Influenza A Treatment
Influenza B Treatment
Major players covered
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peramivir product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peramivir, with price, sales, revenue and global market share of Peramivir from 2018 to 2023.
Chapter 3, the Peramivir competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peramivir breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Peramivir market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peramivir.
Chapter 14 and 15, to describe Peramivir sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Peramivir
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Peramivir Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Solution
1.3.3 Solid
1.4 Market Analysis by Application
1.4.1 Overview: Global Peramivir Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Influenza A Treatment
1.4.3 Influenza B Treatment
1.5 Global Peramivir Market Size & Forecast
1.5.1 Global Peramivir Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Peramivir Sales Quantity (2018-2029)
1.5.3 Global Peramivir Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BioCryst Pharmaceuticals
2.1.1 BioCryst Pharmaceuticals Details
2.1.2 BioCryst Pharmaceuticals Major Business
2.1.3 BioCryst Pharmaceuticals Peramivir Product and Services
2.1.4 BioCryst Pharmaceuticals Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BioCryst Pharmaceuticals Recent Developments/Updates
2.2 Green Cross Pharma
2.2.1 Green Cross Pharma Details
2.2.2 Green Cross Pharma Major Business
2.2.3 Green Cross Pharma Peramivir Product and Services
2.2.4 Green Cross Pharma Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Green Cross Pharma Recent Developments/Updates
2.3 Shionogi Co.
2.3.1 Shionogi Co. Details
2.3.2 Shionogi Co. Major Business
2.3.3 Shionogi Co. Peramivir Product and Services
2.3.4 Shionogi Co. Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shionogi Co. Recent Developments/Updates
2.4 NeoPharm
2.4.1 NeoPharm Details
2.4.2 NeoPharm Major Business
2.4.3 NeoPharm Peramivir Product and Services
2.4.4 NeoPharm Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 NeoPharm Recent Developments/Updates
2.5 Moksha8 Pharma
2.5.1 Moksha8 Pharma Details
2.5.2 Moksha8 Pharma Major Business
2.5.3 Moksha8 Pharma Peramivir Product and Services
2.5.4 Moksha8 Pharma Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Moksha8 Pharma Recent Developments/Updates
2.6 NT Pharma
2.6.1 NT Pharma Details
2.6.2 NT Pharma Major Business
2.6.3 NT Pharma Peramivir Product and Services
2.6.4 NT Pharma Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 NT Pharma Recent Developments/Updates
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Peramivir Product and Services
2.7.4 Merck Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments/Updates
2.8 Hikma Pharmaceuticals
2.8.1 Hikma Pharmaceuticals Details
2.8.2 Hikma Pharmaceuticals Major Business
2.8.3 Hikma Pharmaceuticals Peramivir Product and Services
2.8.4 Hikma Pharmaceuticals Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hikma Pharmaceuticals Recent Developments/Updates
2.9 Hunan Nucien Pharmaceutical Co., Ltd.
2.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Details
2.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Major Business
2.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product and Services
2.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments/Updates
2.10 SCOLR Pharma
2.10.1 SCOLR Pharma Details
2.10.2 SCOLR Pharma Major Business
2.10.3 SCOLR Pharma Peramivir Product and Services
2.10.4 SCOLR Pharma Peramivir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SCOLR Pharma Recent Developments/Updates
3 Competitive Environment: Peramivir by Manufacturer
3.1 Global Peramivir Sales Quantity by Manufacturer (2018-2023)
3.2 Global Peramivir Revenue by Manufacturer (2018-2023)
3.3 Global Peramivir Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Peramivir by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Peramivir Manufacturer Market Share in 2022
3.4.2 Top 6 Peramivir Manufacturer Market Share in 2022
3.5 Peramivir Market: Overall Company Footprint Analysis
3.5.1 Peramivir Market: Region Footprint
3.5.2 Peramivir Market: Company Product Type Footprint
3.5.3 Peramivir Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Peramivir Market Size by Region
4.1.1 Global Peramivir Sales Quantity by Region (2018-2029)
4.1.2 Global Peramivir Consumption Value by Region (2018-2029)
4.1.3 Global Peramivir Average Price by Region (2018-2029)
4.2 North America Peramivir Consumption Value (2018-2029)
4.3 Europe Peramivir Consumption Value (2018-2029)
4.4 Asia-Pacific Peramivir Consumption Value (2018-2029)
4.5 South America Peramivir Consumption Value (2018-2029)
4.6 Middle East and Africa Peramivir Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Peramivir Sales Quantity by Type (2018-2029)
5.2 Global Peramivir Consumption Value by Type (2018-2029)
5.3 Global Peramivir Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Peramivir Sales Quantity by Application (2018-2029)
6.2 Global Peramivir Consumption Value by Application (2018-2029)
6.3 Global Peramivir Average Price by Application (2018-2029)
7 North America
7.1 North America Peramivir Sales Quantity by Type (2018-2029)
7.2 North America Peramivir Sales Quantity by Application (2018-2029)
7.3 North America Peramivir Market Size by Country
7.3.1 North America Peramivir Sales Quantity by Country (2018-2029)
7.3.2 North America Peramivir Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Peramivir Sales Quantity by Type (2018-2029)
8.2 Europe Peramivir Sales Quantity by Application (2018-2029)
8.3 Europe Peramivir Market Size by Country
8.3.1 Europe Peramivir Sales Quantity by Country (2018-2029)
8.3.2 Europe Peramivir Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Peramivir Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Peramivir Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Peramivir Market Size by Region
9.3.1 Asia-Pacific Peramivir Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Peramivir Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Peramivir Sales Quantity by Type (2018-2029)
10.2 South America Peramivir Sales Quantity by Application (2018-2029)
10.3 South America Peramivir Market Size by Country
10.3.1 South America Peramivir Sales Quantity by Country (2018-2029)
10.3.2 South America Peramivir Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Peramivir Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Peramivir Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Peramivir Market Size by Country
11.3.1 Middle East & Africa Peramivir Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Peramivir Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Peramivir Market Drivers
12.2 Peramivir Market Restraints
12.3 Peramivir Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Peramivir and Key Manufacturers
13.2 Manufacturing Costs Percentage of Peramivir
13.3 Peramivir Production Process
13.4 Peramivir Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Peramivir Typical Distributors
14.3 Peramivir Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Peramivir Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Peramivir Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BioCryst Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. BioCryst Pharmaceuticals Major Business
Table 5. BioCryst Pharmaceuticals Peramivir Product and Services
Table 6. BioCryst Pharmaceuticals Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BioCryst Pharmaceuticals Recent Developments/Updates
Table 8. Green Cross Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Green Cross Pharma Major Business
Table 10. Green Cross Pharma Peramivir Product and Services
Table 11. Green Cross Pharma Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Green Cross Pharma Recent Developments/Updates
Table 13. Shionogi Co. Basic Information, Manufacturing Base and Competitors
Table 14. Shionogi Co. Major Business
Table 15. Shionogi Co. Peramivir Product and Services
Table 16. Shionogi Co. Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shionogi Co. Recent Developments/Updates
Table 18. NeoPharm Basic Information, Manufacturing Base and Competitors
Table 19. NeoPharm Major Business
Table 20. NeoPharm Peramivir Product and Services
Table 21. NeoPharm Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. NeoPharm Recent Developments/Updates
Table 23. Moksha8 Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Moksha8 Pharma Major Business
Table 25. Moksha8 Pharma Peramivir Product and Services
Table 26. Moksha8 Pharma Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Moksha8 Pharma Recent Developments/Updates
Table 28. NT Pharma Basic Information, Manufacturing Base and Competitors
Table 29. NT Pharma Major Business
Table 30. NT Pharma Peramivir Product and Services
Table 31. NT Pharma Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. NT Pharma Recent Developments/Updates
Table 33. Merck Basic Information, Manufacturing Base and Competitors
Table 34. Merck Major Business
Table 35. Merck Peramivir Product and Services
Table 36. Merck Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck Recent Developments/Updates
Table 38. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Hikma Pharmaceuticals Major Business
Table 40. Hikma Pharmaceuticals Peramivir Product and Services
Table 41. Hikma Pharmaceuticals Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hikma Pharmaceuticals Recent Developments/Updates
Table 43. Hunan Nucien Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Hunan Nucien Pharmaceutical Co., Ltd. Major Business
Table 45. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product and Services
Table 46. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 48. SCOLR Pharma Basic Information, Manufacturing Base and Competitors
Table 49. SCOLR Pharma Major Business
Table 50. SCOLR Pharma Peramivir Product and Services
Table 51. SCOLR Pharma Peramivir Sales Quantity (Kilotons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. SCOLR Pharma Recent Developments/Updates
Table 53. Global Peramivir Sales Quantity by Manufacturer (2018-2023) & (Kilotons)
Table 54. Global Peramivir Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Peramivir Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 56. Market Position of Manufacturers in Peramivir, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Peramivir Production Site of Key Manufacturer
Table 58. Peramivir Market: Company Product Type Footprint
Table 59. Peramivir Market: Company Product Application Footprint
Table 60. Peramivir New Market Entrants and Barriers to Market Entry
Table 61. Peramivir Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Peramivir Sales Quantity by Region (2018-2023) & (Kilotons)
Table 63. Global Peramivir Sales Quantity by Region (2024-2029) & (Kilotons)
Table 64. Global Peramivir Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Peramivir Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Peramivir Average Price by Region (2018-2023) & (US$/Kg)
Table 67. Global Peramivir Average Price by Region (2024-2029) & (US$/Kg)
Table 68. Global Peramivir Sales Quantity by Type (2018-2023) & (Kilotons)
Table 69. Global Peramivir Sales Quantity by Type (2024-2029) & (Kilotons)
Table 70. Global Peramivir Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Peramivir Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Peramivir Average Price by Type (2018-2023) & (US$/Kg)
Table 73. Global Peramivir Average Price by Type (2024-2029) & (US$/Kg)
Table 74. Global Peramivir Sales Quantity by Application (2018-2023) & (Kilotons)
Table 75. Global Peramivir Sales Quantity by Application (2024-2029) & (Kilotons)
Table 76. Global Peramivir Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Peramivir Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Peramivir Average Price by Application (2018-2023) & (US$/Kg)
Table 79. Global Peramivir Average Price by Application (2024-2029) & (US$/Kg)
Table 80. North America Peramivir Sales Quantity by Type (2018-2023) & (Kilotons)
Table 81. North America Peramivir Sales Quantity by Type (2024-2029) & (Kilotons)
Table 82. North America Peramivir Sales Quantity by Application (2018-2023) & (Kilotons)
Table 83. North America Peramivir Sales Quantity by Application (2024-2029) & (Kilotons)
Table 84. North America Peramivir Sales Quantity by Country (2018-2023) & (Kilotons)
Table 85. North America Peramivir Sales Quantity by Country (2024-2029) & (Kilotons)
Table 86. North America Peramivir Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Peramivir Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Peramivir Sales Quantity by Type (2018-2023) & (Kilotons)
Table 89. Europe Peramivir Sales Quantity by Type (2024-2029) & (Kilotons)
Table 90. Europe Peramivir Sales Quantity by Application (2018-2023) & (Kilotons)
Table 91. Europe Peramivir Sales Quantity by Application (2024-2029) & (Kilotons)
Table 92. Europe Peramivir Sales Quantity by Country (2018-2023) & (Kilotons)
Table 93. Europe Peramivir Sales Quantity by Country (2024-2029) & (Kilotons)
Table 94. Europe Peramivir Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Peramivir Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Peramivir Sales Quantity by Type (2018-2023) & (Kilotons)
Table 97. Asia-Pacific Peramivir Sales Quantity by Type (2024-2029) & (Kilotons)
Table 98. Asia-Pacific Peramivir Sales Quantity by Application (2018-2023) & (Kilotons)
Table 99. Asia-Pacific Peramivir Sales Quantity by Application (2024-2029) & (Kilotons)
Table 100. Asia-Pacific Peramivir Sales Quantity by Region (2018-2023) & (Kilotons)
Table 101. Asia-Pacific Peramivir Sales Quantity by Region (2024-2029) & (Kilotons)
Table 102. Asia-Pacific Peramivir Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Peramivir Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Peramivir Sales Quantity by Type (2018-2023) & (Kilotons)
Table 105. South America Peramivir Sales Quantity by Type (2024-2029) & (Kilotons)
Table 106. South America Peramivir Sales Quantity by Application (2018-2023) & (Kilotons)
Table 107. South America Peramivir Sales Quantity by Application (2024-2029) & (Kilotons)
Table 108. South America Peramivir Sales Quantity by Country (2018-2023) & (Kilotons)
Table 109. South America Peramivir Sales Quantity by Country (2024-2029) & (Kilotons)
Table 110. South America Peramivir Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Peramivir Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Peramivir Sales Quantity by Type (2018-2023) & (Kilotons)
Table 113. Middle East & Africa Peramivir Sales Quantity by Type (2024-2029) & (Kilotons)
Table 114. Middle East & Africa Peramivir Sales Quantity by Application (2018-2023) & (Kilotons)
Table 115. Middle East & Africa Peramivir Sales Quantity by Application (2024-2029) & (Kilotons)
Table 116. Middle East & Africa Peramivir Sales Quantity by Region (2018-2023) & (Kilotons)
Table 117. Middle East & Africa Peramivir Sales Quantity by Region (2024-2029) & (Kilotons)
Table 118. Middle East & Africa Peramivir Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Peramivir Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Peramivir Raw Material
Table 121. Key Manufacturers of Peramivir Raw Materials
Table 122. Peramivir Typical Distributors
Table 123. Peramivir Typical Customers
List of Figures
Figure 1. Peramivir Picture
Figure 2. Global Peramivir Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Peramivir Consumption Value Market Share by Type in 2022
Figure 4. Solution Examples
Figure 5. Solid Examples
Figure 6. Global Peramivir Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Peramivir Consumption Value Market Share by Application in 2022
Figure 8. Influenza A Treatment Examples
Figure 9. Influenza B Treatment Examples
Figure 10. Global Peramivir Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Peramivir Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Peramivir Sales Quantity (2018-2029) & (Kilotons)
Figure 13. Global Peramivir Average Price (2018-2029) & (US$/Kg)
Figure 14. Global Peramivir Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Peramivir Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Peramivir by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Peramivir Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Peramivir Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Peramivir Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Peramivir Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Peramivir Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Peramivir Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Peramivir Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Peramivir Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Peramivir Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Peramivir Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Peramivir Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Peramivir Average Price by Type (2018-2029) & (US$/Kg)
Figure 29. Global Peramivir Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Peramivir Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Peramivir Average Price by Application (2018-2029) & (US$/Kg)
Figure 32. North America Peramivir Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Peramivir Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Peramivir Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Peramivir Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Peramivir Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Peramivir Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Peramivir Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Peramivir Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Peramivir Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Peramivir Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Peramivir Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Peramivir Consumption Value Market Share by Region (2018-2029)
Figure 52. China Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Peramivir Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Peramivir Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Peramivir Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Peramivir Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Peramivir Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Peramivir Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Peramivir Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Peramivir Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Peramivir Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Peramivir Market Drivers
Figure 73. Peramivir Market Restraints
Figure 74. Peramivir Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Peramivir in 2022
Figure 77. Manufacturing Process Analysis of Peramivir
Figure 78. Peramivir Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
